← Back to Search

Break the Cycle Intervention for Intravenous Drug Use

N/A
Waitlist Available
Led By Don Des Jarlais, PhD
Research Sponsored by New York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial is testing whether a motivational intervention can reduce the number of people who help others inject drugs for the first time, and promote injection drug use among non-PWID.

Eligible Conditions
  • Prevention and Control
  • Intravenous Drug Use

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants helping with first injections
Secondary outcome measures
Number of participants injecting in front of other people
Number of participants offering to give first injection
Number of participants who say positive things

Trial Design

1Treatment groups
Experimental Treatment
Group I: Break the Cycle InterventionExperimental Treatment1 Intervention
All study participants are assigned to this experimental arm.

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor
228 Previous Clinical Trials
312,659 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,503 Previous Clinical Trials
2,625,183 Total Patients Enrolled
University of TartuOTHER
53 Previous Clinical Trials
43,398 Total Patients Enrolled
~45 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top